Intellectual Property Magazine
ERS Genomics brings in new IP VP
ERS Genomics, the company which holds the exclusive worldwide license to Emmanuelle Charpentier’s CRISPR-Cas9 IP rights, has
appointed Michael Arciero as vice president of IP and Commercial Development.